{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T15:32:24Z","timestamp":1767108744008,"version":"3.45.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,1,29]],"date-time":"2021-01-29T00:00:00Z","timestamp":1611878400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000361","name":"Diabetes UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000361","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["STAR Protocols"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/j.xpro.2021.100355","type":"journal-article","created":{"date-parts":[[2021,3,2]],"date-time":"2021-03-02T00:05:00Z","timestamp":1614643500000},"page":"100355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Measurement of intraorgan fat and hepatic output of triglycerides in human type 2 diabetes by magnetic resonance and intralipid infusion techniques"],"prefix":"10.1016","volume":"2","author":[{"given":"Ahmad","family":"Al-Mrabeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl","family":"Peters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kieren G.","family":"Hollingsworth","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xpro.2021.100355_bib1","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S2213-8587(20)30303-X","article-title":"2-year remission of type 2 diabetes and pancreas morphology: a post-hoc analysis of the DiRECT open-label, cluster-randomised trial","volume":"8","author":"Al-Mrabeh","year":"2020","journal-title":"Lancet Diabetes Endocrinol."},{"key":"10.1016\/j.xpro.2021.100355_bib2","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1007\/s00125-016-3984-6","article-title":"Morphology of the pancreas in type 2 diabetes: effect of weight loss with or without normalisation of insulin\u00a0secretory capacity","volume":"59","author":"Al-Mrabeh","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/j.xpro.2021.100355_bib3","doi-asserted-by":"crossref","first-page":"e0174660","DOI":"10.1371\/journal.pone.0174660","article-title":"Quantification of intrapancreatic fat in type 2 diabetes by MRI","volume":"12","author":"Al-Mrabeh","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.xpro.2021.100355_bib4","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.cmet.2019.11.018","article-title":"Hepatic lipoprotein export and remission of human type 2 diabetes after weight loss","volume":"31","author":"Al-Mrabeh","year":"2020","journal-title":"Cell Metab."},{"key":"10.1016\/j.xpro.2021.100355_bib5","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1194\/jlr.D600044-JLR200","article-title":"Development of a novel method to determine very low density lipoprotein kinetics","volume":"48","author":"Al-Shayji","year":"2007","journal-title":"J Lipid Res."},{"key":"10.1016\/j.xpro.2021.100355_bib6","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S0022-2275(20)37637-9","article-title":"Accumulation of large very low density lipoprotein in plasma during intravenous infusion of a chylomicron-like triglyceride emulsion reflects competition for a common lipolytic pathway","volume":"37","author":"Bjorkegren","year":"1996","journal-title":"J Lipid Res."},{"key":"10.1016\/j.xpro.2021.100355_bib7","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1002\/mrm.1910180211","article-title":"Three-point Dixon technique for true water\/fat decomposition with B0 inhomogeneity correction","volume":"18","author":"Glover","year":"1991","journal-title":"Magn. Reson. Med."},{"key":"10.1016\/j.xpro.2021.100355_bib8","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1016\/S0022-2275(20)38064-0","article-title":"Surface modification of Beckman ultra-clear centrifuge tubes for density gradient centrifugation of lipoproteins","volume":"23","author":"Holmquist","year":"1982","journal-title":"J Lipid Res."},{"key":"10.1016\/j.xpro.2021.100355_bib9","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/jmri.24289","article-title":"Quantitative chemical shift-encoded MRI is an accurate method to quantify hepatic steatosis","volume":"39","author":"K\u00fchn","year":"2014","journal-title":"J.\u00a0Magn. Reson. Imaging"},{"key":"10.1016\/j.xpro.2021.100355_bib10","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1007\/s00125-011-2204-7","article-title":"Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol","volume":"54","author":"Lim","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/j.xpro.2021.100355_bib11","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/BF02533063","article-title":"Subfractionation of S f 4-10 5 , S f 4-20 and high density lipoproteins","volume":"7","author":"Lindgren","year":"1972","journal-title":"Lipids"},{"key":"10.1016\/j.xpro.2021.100355_bib12","doi-asserted-by":"crossref","first-page":"808","DOI":"10.2337\/dc15-1942","article-title":"Very low calorie diet and 6\u00a0months of weight stability in type 2 diabetes: pathophysiological changes in responders and nonresponders","volume":"39","author":"Steven","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.xpro.2021.100355_bib13","doi-asserted-by":"crossref","first-page":"158","DOI":"10.2337\/dc15-0750","article-title":"Weight loss decreases excess pancreatic triacylglycerol specifically in type 2 diabetes","volume":"39","author":"Steven","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/j.xpro.2021.100355_bib14","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.cmet.2018.07.003","article-title":"Remission of human type\u00a02\u00a0diabetes requires decrease in liver and pancreas fat content but is dependent upon capacity for beta cell recovery","volume":"28","author":"Taylor","year":"2018","journal-title":"Cell Metab."}],"container-title":["STAR Protocols"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666166721000629?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666166721000629?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,12]],"date-time":"2025-11-12T19:45:12Z","timestamp":1762976712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666166721000629"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S2666166721000629"],"URL":"https:\/\/doi.org\/10.1016\/j.xpro.2021.100355","relation":{},"ISSN":["2666-1667"],"issn-type":[{"type":"print","value":"2666-1667"}],"subject":[],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Measurement of intraorgan fat and hepatic output of triglycerides in human type 2 diabetes by magnetic resonance and intralipid infusion techniques","name":"articletitle","label":"Article Title"},{"value":"STAR Protocols","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xpro.2021.100355","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.cmet.2018.07.003","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/j.cmet.2019.11.018","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s).","name":"copyright","label":"Copyright"}],"article-number":"100355"}}